Reaction
Chloroma reporting signals
As of the last recalculation, Chloroma appears in 417 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 133.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 26 | 133.9 | 134.3 |
| Azacitidine | 39 | 72.3 | 72.4 |
| Blinatumomab | 14 | 69.3 | 69.4 |
| Cytarabine | 69 | 68.5 | 68.6 |
| Azacitidine For | 22 | 63.7 | 63.8 |
| Imatinib | 20 | 59.4 | 59.5 |
| Busulfan | 16 | 52.7 | 52.8 |
| Fludarabine Phosphate | 36 | 49.9 | 50.0 |
| Mesna Injection | 7 | 43.0 | 43.0 |
| Mesna | 7 | 42.2 | 42.2 |
| Tretinoin | 6 | 37.4 | 37.4 |
| Etoposide | 47 | 35.8 | 35.9 |
| Mercaptopurine | 12 | 35.5 | 35.6 |
| Imatinib Mesylate | 18 | 33.6 | 33.6 |
| Nilotinib | 16 | 28.1 | 28.1 |
| Cisplatin | 33 | 22.8 | 22.8 |
| Venetoclax | 26 | 22.4 | 22.4 |